Skip to main content
ASKA Pharmaceutical Holdings Co., Ltd.ASKA Pharmaceutical Holdings Co., Ltd.
  • Contact Us
  • Accessibility
LANGUAGE
JP
EN
  • HOME
    • About ASKA Pharmaceutical Holdings
      • Top Message
      • Corporate Philosophy
      • Company Overview
      • Charter of Corporate Behavior
      • Board Members and Corporate Officers
      • Company Information
      • Group Companies
      • Business Activities
      • Corporate Message
      • Digital Transformation
      • ASKA Pharmaceutical Holdings in Numbers
    • For Our Shareholders and Investors
      • Top Message
      • IR News
      • IR Library
      • IR Calendar
      • Management Strategies and Policies
      • Governance
      • Financial Highlights
      • ASKA Pharmaceutical Holdings at a glance
      • IR Related Information
      • Stock and Shareholder Information
    • Sustainability
      • Our Sustainability
      • Environmental
      • Social
      • Governance (Related Link)
      • ESG Chart and ESG Data Book
      • External Evaluation
      • Initiatives and Member Organizations
      • Third-party Opinion
      • Sustainability News
      • Various Contrasting Tables
      • Policies (Related Link)
      • Integrated Report (Related Link)
    • Press Releases
    • Contact Us
    • Privacy Policy
    • Basic Policy on the Proper Handling of Specific Personal Information, etc.
    • Terms of Use
    • Web Accessibility Policy
    • SNS Community Guidelines
      • Official website and SNS
    • Sitemap
    • Search Results
    • Important Notice
About ASKA Pharmaceutical Holdings
  • Company Overview
  • Group Companies
  • Top Message
  • Corporate Philosophy
  • Charter of Corporate Behavior
  • Board Members and Corporate Officers
  • Company Information
  • Business Activities
  • Corporate Message
  • Digital Transformation
  • ASKA Pharmaceutical Holdings in Numbers
For Our Shareholders and Investors
  • Top Message
  • Management Strategies and Policies
  • IR News
  • IR Library
  • IR Calendar
  • Governance
  • Financial Highlights
  • ASKA Pharmaceutical Holdings at a glance
  • IR Related Information
  • Stock & Shareholder Information
Sustainability
  • Integrated Report (Related links)
  • Our Basic Policy for Sustainability
  • Various Contrasting Tables
  • Our Sustainability
    • Top Commitment
    • Our Basic Policy for Sustainability
    • Materiality
    • Value Creation Process
    • Capital and Strengths
    • Initiatives for Sustainability and SDGs
    • Importance of Female Healthcare and Social Issues
    • Disclosures based on TCFD recommendations
    • Disclosures based on TNFD recommendations
  • Environmental Governance (Related links) External Evaluation Third-party Opinion Various Contrasting Tables Integrated Report (Related links)
  • Social ESG Chart and ESG Data Book Initiatives and Member Organizations Sustainability News Policies (Related links)
[ Important Notice ] Alert on False Emails Impersonating the Representative Director of ASKA Pharmaceutical Co., Ltd.
[ Important Notice ]
Alert on False Emails Impersonating the Representative Director of ASKA Pharmaceutical Co., Ltd.

NEWS RELEASES

RSS
  • May 22 2026
    We have added “Don't Miss It! Understanding Thyroid Disorders” to the Mint⁺ Women's Health Lab series, “What Every Woman Should Know About Her Body and Health.” (Japanese version only)
  • May 22 2026
    Mint+Hug's “Column for Newborns and Infants” has been updated with “Dads' Real-Life Guide: Childbirth and Infancy.”(Japanese version only) 
  • April 17 2026
    ASKA Places Interview Advertisement with President Yamaguchi in Investment Magazine Kabunushi Techou [PDF](Japanese version only)4.25 MB
  • March 09 2026
    ASKA Pharmaceutical Holdings Group Recognized as Enterprise in Outstanding Organizations of KENKO Investment for Health Program[PDF]187.68 KB
  • February 19 2026
    ASKA Pharmaceutical and SMFL MIRAI Partners Sign Heat Recovery Heat Pump Energy Service Contract[PDF]353.96 KB
NEWS RELEASES

IR NEWS

RSS
IR NEWS

IR E-mail Newsletter Service

Receive our latest IR information by e-mail.

Subscribe to the Service

ASKA VISION 2035

Toward a Specialty Healthcare Company Based in Japan,
Pioneering the Future Globally

ASKA Pharmaceutical Holdings Long-Term Vision

ASKA Pharmaceutical Holdings Group

ASKA Pharmaceutical Holdings Group

  • ASKA Pharmaceutical Co., Ltd.
  • ASKA Animal Health Co., Ltd.
    (Japanese version only)
  • ASKA Pharma Medical Co., Ltd.
    (Japanese version only)

For Our Shareholders and Investors

  • Top Message
  • Financial Highlights
  • Integrated Report
  • Medium-Term Management Plan
  • ASKA Pharmaceutical Holdings at a glance
  • IR Library
  • IR Calendar
  • Management Strategies and Policies
  • Governance
  • IR Related Information
  • Stock & Shareholder Information

About ASKA Pharmaceutical Holdings

  • Company Profile

    • Top Message
    • Corporate Philosophy
    • Company Overview
    • Charter of Corporate Behavior
    • Board Members and Corporate Officers
    • Company Information
    • Group Companies
    • Business Activities
    • Corporate Message
    • Digital Transformation
    • ASKA Pharmaceutical Holdings in Numbers
  • Sustainability

    • Top Commitment
    • Our Basic Policy for Sustainability
    • Materiality
    • Value Creation Process
    • Capital and Strengths
    • Initiatives for Sustainability and SDGs
    • Importance of Female Healthcare and Social Issues
    • Disclosures based on TCFD recommendations
    • Disclosures based on TNFD recommendations
    • Environmental
    • Social
    • Corporate Governance (Related links)
    • ESG Chart and ESG Data Book
    • External Evaluation
    • Initiatives and Member Organizations
    • Third-party Opinion
    • Sustainability News
    • Various Contrasting Tables
    • Policies (Related links)
    • Integrated Report (Related links)
  • Privacy Policy
  • Basic Policy on the Proper Handling of Specific Personal Information, etc.
  • Terms of Use
  • Web Accessibility Policy
  • SNS Community Guidelines
  • Sitemap
Copyright © ASKA Pharmaceutical Holdings Co., Ltd. All Rights Reserved.
TOP
TDBRQfRygFlNgQ44lgJuHWQbi0T7bvk7IVb6gvQqb-E=.html